[Gecacitinib as a bridging treatment to allogeneic hematopoietic stem cell transplantation for high-risk myelodysplastic syndrome with Behçet's syndrome: a case report].

Authors

W Wu, G F Mu, H M Zhu, Z Q Sun

Published in

Zhonghua nei ke za zhi. Volume 65. Issue 10. Pages 1111-1112. Oct 01, 2026.

PMID:
42855759
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.